Suggests two mechanisms behind the potential pathogenic role of glutamic acid decarboxylase autoantibodies (GAD-Ab) in neurological disorders. Reduction by GAD-Ab of gamma-aminobutyric acid (GABA) synthesis in nerve terminals; Interference with exocytosis of GABA.